Literature DB >> 7607761

Non-haemorrhagic adverse reactions of oral anticoagulant therapy.

M Gallerani1, R Manfredini, S Moratelli.   

Abstract

Oral anticoagulants are extensively used in everyday medical practice, especially for the prophylaxis of deep vein thrombosis and pulmonary thromboembolism. Bleeding is the major risk of such therapy. Although infrequent, however, non-haemorrhagic complications may also play a considerable role. The purpose of this paper is briefly to review the most important non-haemorrhagic adverse reactions and their clinical signs. Moreover, the pathogenetic hypotheses, the relationships with protein C and S levels, and the possibility of prevention and treatment are also discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7607761     DOI: 10.1016/0167-5273(95)02279-6

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Warfarin-induced purple toe syndrome successfully treated with apixaban.

Authors:  Holly E Cakebread; Hui Min Knight; Parag R Gajendragadkar; John P Cooper
Journal:  BMJ Case Rep       Date:  2014-06-12

2.  Warfarin-induced leukocytoclastic vasculitis and proteinuria.

Authors:  Khalid Jumean; Ahmad Abu Arqoub; Amer Hawatmeh; Firas Qaqa; Ayham Bataineh; Hamid Shaaban
Journal:  J Family Med Prim Care       Date:  2016 Jan-Mar

3.  Warfarin skin necrosis mimicking calciphylaxis in a patient with secondary hyperparathyroidism undergoing peritoneal dialysis.

Authors:  Jee Eun Park; Seonggyu Byeon; Hee Kyung Kim; Seong Mi Moon; Ji Hoon Moon; Kee-Taek Jang; Byung-Jae Lee; Hye Ryoun Jang; Wooseong Huh; Dae Joong Kim; Yoon-Goo Kim; Ha Young Oh; Jung Eun Lee
Journal:  Kidney Res Clin Pract       Date:  2015-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.